EUVIMEDEUVIMED entdecken
Crossref

CCR5 ‐Mediated Reprogramming of Regulatory T Cells and Monocytic‐Myeloid‐Derived Suppressor Cells in Young Dyslipidemic Individuals: A Plausible Therapeutic Approach

Komal Sagar, Shamima Akhtar, Nikita Kumar, Anil Kumar Tomar, Ambuj Roy, Milind P Hote, Sudheer Arava, Savita Yadav, Alpana Sharma

Immunology · 2025

DOI: 10.1111/imm.13941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Komal Sagar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences, AIIMS, New Delhi, India. Hauptthemen laut MEDLINE: Receptors, CCR5, T-Lymphocytes, Regulatory, Monocytes, Dyslipidemias. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: University Grants Commission, India, Indian Council of Medical Research, University Grants Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemokine receptor CCR5 is upregulated in the regulatory T cells (Tregs) and monocytic‐myeloid‐derived suppressor cells (M‐MDSCs) of young dyslipidemic individuals. In this study, we investigated the role of CCR5 in regulating the phenotypic and functional plasticity of Tregs and M‐MDSCs during the preclinical phase of atherosclerosis. Inflammatory conditions induce a phenotypic shift in Tregs and M‐MDSCs, characterised by enhanced expression of CCR5 and pro‐inflammatory cytokines. Tregs from dyslipidemic (DLP) and coronary artery disease (CAD) patients exhibited a mixed Th1/Th17/Treg phenotype, whilst M‐MDSCs displayed elevated markers of activation and inflammation. CCR5 inhibition via DAPTA (10 −8 M) restored the immune suppressive phenotype and function of Tregs and M‐MDSCs in vitro. Migration of dysfunctional Tregs and M‐MDSCs to CCL5 stimulus was also reduced after DAPTA treatment in vitro. In vivo, DAPTA reduced IL‐12 expression and elevated IL‐10 expression in Tregs and M‐MDSCs. Therapeutically targeting CCR5 in Tregs and M‐MDSCs of young naive dyslipidemic individuals aids in the dampening of early inflammation and can prevent the progression of atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR5T-Lymphocytes, RegulatoryMonocytesDyslipidemiasHumansMaleFemaleAnimalsAdultMiddle AgedAtherosclerosisMiceCoronary Artery DiseaseCytokinesCells, CulturedCCR5 Receptor AntagonistsCellular Reprogramming

Stichwörter der Autor:innen

CCR5DAPTAM‐MDSCTregsatherosclerosisimmunosuppressionintermediate phenotype

Substanzen

Receptors, CCR5CCR5 protein, humanCytokinesCCR5 Receptor Antagonists

Autor:innen und Institutionen

  • Department of Biochemistry, All India Institute of Medical Sciences, AIIMS, New Delhi, India.
  • Department of Biophysics, AIIMS, New Delhi, India.
  • Department of Cardiology, AIIMS, New Delhi, India.
  • Department of Cardiothoracic and Vascular Surgery, AIIMS, New Delhi, India.
  • Department of Pathology, AIIMS, New Delhi, India.

Förderung

  • University Grants Commission, India
  • Indian Council of Medical Research
  • University Grants Commission

Zitieren

APA

Sagar, K., Akhtar, S., Kumar, N., Tomar, A. K., Roy, A., Hote, M. P., Arava, S., Yadav, S., & Sharma, A. (2025). CCR5 ‐Mediated Reprogramming of Regulatory T Cells and Monocytic‐Myeloid‐Derived Suppressor Cells in Young Dyslipidemic Individuals: A Plausible Therapeutic Approach. Immunology. https://doi.org/10.1111/imm.13941

Vancouver

Sagar K, Akhtar S, Kumar N, Tomar AK, Roy A, Hote MP, et al. CCR5 ‐Mediated Reprogramming of Regulatory T Cells and Monocytic‐Myeloid‐Derived Suppressor Cells in Young Dyslipidemic Individuals: A Plausible Therapeutic Approach. Immunology. 2025. doi:10.1111/imm.13941

BibTeX
@article{Sagar2025,
  author = {Sagar, Komal and Akhtar, Shamima and Kumar, Nikita and Tomar, Anil Kumar and Roy, Ambuj and Hote, Milind P and Arava, Sudheer and Yadav, Savita and Sharma, Alpana},
  title = {CCR5 ‐Mediated Reprogramming of Regulatory T Cells and Monocytic‐Myeloid‐Derived Suppressor Cells in Young Dyslipidemic Individuals: A Plausible Therapeutic Approach},
  journal = {Immunology},
  year = {2025},
  doi = {10.1111/imm.13941}
}
Kostenlos starten →